April 03, 2024

Upgraded Digital Platform Provides Improved User Experience, QuickStart Program for
MiSight® 1 day Certification, and Enhanced Tools for Staff Training

SAN RAMON, CALIF., April 3, 2024—As part of its ongoing commitment to provide eye care professionals (ECPs) with educational tools, resources, and practice support, CooperVision today announced the launch of its redesigned Online Success Center (OSC). The upgraded, on-demand digital platform features an enhanced look and feel, providing users with an improved, immersive educational experience, more robust resources, and a streamlined myopia control and myopia management certification process. The easy-to-use platform also delivers practical tools to empower staff with new knowledge and skills they can implement in practice.

“Through our work with the eye care community, we kept hearing from ECPs that finding, training and retaining staff members is a primary concern in their day-to-day operations,” said Jennifer Palombi, OD, FAAO, CooperVision Head of Professional Education and Development, Americas. “Our plan to partner with practices to help train new and existing staff members through these added resources will help to lighten the load on ECPs and boost practice efficiencies.”

The OSC’s redesigned myopia category now makes it easier than ever for ECPs to get started with MiSight® 1 day*, for age-appropriate children, through the new QuickStart program. The program includes a flagship, 15-minute QuickStart video and other quick-hitting resources aimed at helping ECPs get up and running quickly with myopia management, while delivering impactful myopia conversations with patients and parents. Also new to the myopia category is the Paragon CRT® Certification Program, which offers ECPs the opportunity to complete the Paragon CRT® certification process in as little as 45 minutes.

“Myopia’s prevalence and severity continues to grow at epidemic rates.1,2 As such, myopia management has become essential for ECPs to incorporate into their practices—if they haven’t already,” said Louise Curcio, Director of Myopia Management, CooperVision, Americas. “With the addition of the QuickStart program and Paragon CRT® certification to the OSC, our goal is to provide practitioners with additional options to manage patients facing this crucial issue.”

In addition to myopia management, the newly redesigned learning platform offers numerous interactive courses spanning across seven categories, which encompass every facet of what’s important to a successful contact lens practice, including the enhanced staff training section. Other key category updates include CooperVision Technology & Programs, Spheres & Digital Lifestyles, and New to Practice—which includes tips and advice for young ODs just getting started in their careers.

Access CooperVision’s redesigned Online Success Center at CooperVision Online Success Center: Log in to the site.


* U.S. Indications for Use: MiSight® 1 day (omafilcon A) soft (hydrophilic) contact lenses for daily wear are indicated for the correction of myopic ametropia and for slowing the progression of myopia in children with non-diseased eyes, who at the initiation of treatment are 8-12 years of age and have a refraction of -0.75 to -4.00 diopters (spherical equivalent) with ≤ 0.75 diopters of astigmatism. The lens is to be discarded after each removal. 

1. Holden BA, Fricke TR, Wilson DA, et al. Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050. Ophthalmology. 2016;123(5):1036-1042. doi:10.1016/j.ophtha.2016.01.006.
2. American Academy of Ophthalmology Leads Global Initiative to address worldwide myopia epidemic. American Academy of Ophthalmology. (2020, November 11). https://www.aao.org/newsroom/news-releases/detail/academy-leads-initiative-to-address-myopia

About CooperVision
CooperVision, a division of CooperCompanies (Nasdaq:COO), is one of the world’s leading manufacturers of contact lenses. The company produces a full array of daily disposable, two-week and monthly soft contact lenses that feature advanced materials and optics, and premium rigid gas permeable lenses for orthokeratology and scleral designs. CooperVision has a strong heritage of addressing the toughest vision challenges such as astigmatism, presbyopia, childhood myopia, and highly irregular corneas; and offers the most complete portfolio of spherical, toric and multifocal products available. Through a combination of innovative products and focused practitioner support, the company brings a refreshing perspective to the marketplace, creating real advantages for customers and wearers. For more information, visit www.coopervision.com

About CooperCompanies
CooperCompanies (Nasdaq: COO) is a leading global medical device company focused on improving lives one person at a time. The Company operates through two business units, CooperVision and CooperSurgical. CooperVision is a trusted leader in the contact lens industry, improving the vision of millions of people every day. CooperSurgical is a leading fertility and women’s health company dedicated to assisting women, babies and families at the healthcare moments that matter most. Headquartered in San Ramon, Calif., CooperCompanies has a workforce of more than 15,000 with products sold in over 130 countries. For more information, please visit www.coopercos.com

Media Contact
Maggie O’Donoghue, Counselor
McDougall Communications for CooperVision
maggie@mcdougallpr.com or +1-585-208-8534